CervoMed Inc — Dividend History & Yield (NASDAQ:CRVO) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

新闻

CervoMed的neflamapimod入选英国ALS试验平台

CervoMed’s neflamapimod selected for UK ALS trial platform

Cantor Fitzgerald 给予 CervoMed 股票"增持"评级

Cantor Fitzgerald initiates CervoMed stock with Overweight rating

CervoMed股价在有前景的痴呆症药物试验结果后飙升

CervoMed的路易体痴呆症药物在2b期临床试验中显示前景

CervoMed’s DLB drug shows promise in phase 2b trial

CervoMed stock soars after promising dementia drug trial results

Neflamapimod reduces key neurodegeneration markers in DLB study

CervoMed Inc.：首席商务官Winton购入价值4.143万美元CRVO股票

CervoMed首席执行官Alam购买价值182,736美元的股票

葛雷瓜尔·西尔维以182,736美元购入CervoMed (CRVO)股票